Qiufen He Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2023

Targeting TRMT5 suppresses hepatocellular carcinoma progression via inhibiting the HIF-1α pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiufen He Research Topics

Disease

2	Deafness (Deaf Mutism) 12/2020 - 11/2020
2	Hypertension (High Blood Pressure) 01/2018 - 01/2017
1	Carcinogenesis 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Hearing Loss (Hearing Impairment) 12/2020
1	Sensorineural Hearing Loss 12/2020
1	Nonsyndromic sensorineural hearing loss 12/2020
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2016

Drug/Important Bio-Agent (IBA)

4	Transfer RNA (tRNA)IBA 01/2023 - 01/2017
4	Mitochondrial DNA (mtDNA)IBA 11/2020 - 01/2016
1	Oxygen (Dioxygen)IBA 01/2023
1	tRNA MethyltransferasesIBA 01/2023
1	microtubule-associated protein 1B (MAP5)IBA 12/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2020
1	PhosphoproteinsIBA 12/2020
1	Asp Transfer RNAIBA 11/2020
1	Ser Transfer RNAIBA 11/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	NucleotidesIBA 01/2018
1	Met Transfer RNAIBA 01/2018
1	Codon (Codons)IBA 01/2018
1	AnticodonIBA 01/2018
1	Leu Transfer RNAIBA 01/2017

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2023
1	Therapeutics 01/2023